Tessera Therapeutics
Gregory Gallais currently serves as Manager of Laboratory Operations at Tessera Therapeutics, having progressed through various roles including Senior Specialist and Specialist II in Lab Operations since September 2021. Prior experience includes being an Account Manager and Lab Manager at Matrivax Corporation, where responsibilities encompassed organizing lab procedures and managing inventory. Additional roles include Legal Assistant at Harmon Law Offices, Research Assistant at Salem State University, Assistant Manager at Epicurean Feast, and various managerial positions in retail and banking. Gregory holds a Bachelor of Science in Business Administration from Salem State University and an Associate of Arts from Bunker Hill Community College.
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.